VYNE Therapeutics
-$0.17 (-4.46%) Today
+$0.01 (+0.27%) As of 9:07 PM UTC after-hours
Why Robinhood?
You can buy or sell VYNE and other stocks, options, and ETFs commission-free!
About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology.
CEO
David Domzalski
Employees
106
Headquarters
Bridgewater, New Jersey
Founded
—
VYNE Key Statistics
Market Cap
192.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
858.47K
High Today
$3.85
Low Today
$3.60
Open Price
$3.84
Volume
1.02M
52 Week High
$13.20
52 Week Low
$3.11
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
VYNE Earnings
-$0.95
-$0.63
-$0.32
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market